Register

Main Theme

The determinants of health and well-being are often driven by the interests of big players, which are not always aligned with public health agendas. In order to purposefully engage with these giants while safeguarding the interests of people, we need to conceptualise new partnership models – learn to “dance with elephants” - but we should be careful not to get our toes crushed. The COVID-19 pandemic has put into sharp focus the current fault lines in our systems and highlighted the need for true cross-sector and cross-border collaboration.

Read More

#EHFG2020

Meet some of our

HIGH-LEVEL SPEAKERS

Christopher Fearne
MT

Christopher Fearne

Deputy Prime Minister and Minister for Health, Republic of Malta

Rudolf Anschober
AT

Rudolf Anschober

Minister of Social Affairs, Health, Care and Consumer Protection, Austria

Maggie De Block
BE

Maggie De Block

Minister of Social Affairs and Public Health, and Asylum and Migration, Belgium

Marta Temido
PT

Marta Temido

Minister of Health, Portuguese Republic

Tomaž Gantar
SI

Tomaž Gantar

Minister of Health, Republic of Slovenia

Aurelijus Veryga
LT

Aurelijus Veryga

Minister of Health, Republic of Lithuania

Stella Kyriakides
EC

Stella Kyriakides

Commissioner for Health and Food Safety, European Commission

Hans Kluge
WHO

Hans Kluge

Regional Director for Europe, World Health Organization

Mohammed Chahim
NL

Mohammed Chahim

MEP, European Parliament

Cristian-Silviu Buşoi
RO

Cristian-Silviu Buşoi

MEP, European Parliament

Thomas Steffen
DE

Thomas Steffen

State Secretary, Federal Ministry of Health, Germany

Maja Fjaestad
SE

Maja Fjaestad

State Secretary, Ministry for Health and Social Affairs, Sweden

Andrei Baciu
RO

Andrei Baciu

State Secretary, Ministry of Health Romania

Sandra Gallina
EC

Sandra Gallina

Deputy Director-General, European Commission Directorate-General for Health and Food Safety

Andrea Ammon
ECDC

Andrea Ammon

Director, European Centre for Disease Prevention and Control

Bente Mikkelsen
WHO

Bente Mikkelsen

Director, World Health Organization Headquarters

Bjørn-Inge Larsen
NO

Bjørn-Inge Larsen

Secretary-General, Norwegian Ministry of Health and Careservices

Vytenis Andriukaitis
WHO

Vytenis Andriukaitis

Special Envoy for the European Region, World Health Organization

Katherine Trebeck
WEAll

Katherine Trebeck

Advocacy and Influencing Lead, Wellbeing Economy Alliance

Carly Kind
ADA

Carly Kind

Director, Ada Lovelace Institute

Casper Klynge
Microsoft

Casper Klynge

Vice President, Microsoft Corporation

Colin Crouch
MPI

Colin Crouch

External Scientific Member, Max Planck Institute for the Study of Societies

Ilona Kickbusch
IHEID

Ilona Kickbusch

Founding Director Global Health Programme, Graduate Institute Geneva

Programme Details

  • Day 1  |  30.09.2020Wed
  • Day 2  |  01.10.2020Thu
  • Day 3  |  02.10.2020Fri
Swipe
  • Advancing innovation
  • Resilient systems
  • From data to decisions
  • Empowerment and agency
  • Plenary
  • Evening Event

Topic Tracks

Advancing innovation

2020 has brought the need to look at innovation through a new lens: the challenges we have faced due to COVID-19 have accelerated innovation of approaches and technology in many areas. But are these changes sustainable, and are they inclusive? How can we ensure the fruits of innovation benefit all and contribute to a more resilient future while protecting the most vulnerable?

 

This track will explore how stakeholders in health can wield innovation to help us tango with the ‘elephants’ of the present and future, and tackle lasting challenges such as AMR, telemedicine and artificial intelligence.

Resilient systems

The COVID-19 pandemic has exposed the fault lines in our health systems, but also opened a window of opportunity to move on from “business as usual” and redefine our priorities in health and beyond. How will we bounce back from an unprecedented crisis together?

 

This track will explore the necessity to invest in resilient, transparent and equitable structures, bring young voices to the table, re-think our enduring challenges, and lead the way to not just a ‘new normal’, but a ‘better normal’.

From data to decisions

The relationship between how much or how little we know and how best we can use that knowledge for policy and practice has been upended during the COVID-19 outbreak. The questions raised go well beyond the pandemic: How can we effect speedy responses at times when evidence is scarce, or the quality of data is poor? How can we succeed in transferring solutions and learnings across different places, disease areas and policy questions?

 

This track will look at the challenges of collating and translating knowledge into action, dealing with uncertainties, and scaling up best practices.

Empowerment and agency

This year, the EHFG is putting a focus on big issues and big players in health, democracy and business, and considering how different stakeholders can engage in a ‘dance’ with these giants. What place do people have in this reckoning with the larger currents of commercial and political determinants of health?

 

In this track, sessions will focus on how to enable agency on a civil society level and empower people as strong actors - be it through finding participatory modes of governance, leveling the playing field when it comes to access inequalities to care or information, or making sure the needs of patients are heard.

Get in touch

If you have any questions about the conference, drop us a message at office@ehfg.org.

We look forward to seeing you online at the EHFG 2020!